Heart disease continues to be the leading cause of death for both men and women in the United States— responsible for one in every five deaths. Longevity Health and Young Heart Group aim to change that.

Located in Innovation Park, Longevity Health is the first of its kind in Tennessee. Founded by philanthropist and entrepreneur George Shinn and his wife, Megan, the focus of the practice is early screening and detection of certain cancers and heart disease providing each patient with a clear understanding of their health.

Motivated by their faith-driven mission to help save lives, the Shinns shared: “With this cutting-edge technology and an exceptional team delivering compassionate, high-quality care, our mission is simple: extend life and elevate health.” 

Longevity Health has partnered with Young Heart Group, a prevention focused concierge cardiology practice led by Dr. Kevin Young who serves as the medical director of Longevity Health. Young Heart Group shares an office with Longevity Health and offers cardiovascular risk assessments and annual memberships as a part of their practice

While screening for early detection of cancer is standard practice, a reliable screening method for the early detection of heart disease has not been a part of mainstream healthcare until now. Longevity Health offers advanced coronary artery disease screening with the integration of Coronary Computed Tomography Angiography (coronary CTA) combined with artificial intelligence (AI) to create a 3D model of the heart arteries and detailed vessel-by-vessel evaluation. Longevity Health has partnered with two AI-technology based companies–Cleerly® and Heartflow®. The scan itself is noninvasive and takes less than ten minutes. Longevity Health is the first and only clinic in Tennessee to offer Cleerly technology providing the ability to identify, quantify and assess for artery blockage. This is a repeatable test so that plaque can be tracked over time. Heartflow is an artificial intelligence (AI) AI analysis platform that can provide plaque analysis and assessment of blood flow anywhere in the coronary arteries. The use of these AI imaging technologies find what other conventional diagnostic tests simply can’t see. 

“We’re empowering patients with a breakthrough in preventative care—an advanced diagnostic solution that can detect life-threatening conditions before they become emergencies,” says Russell McBryde, Longevity Health CEO. 

Many people wonder how this type of evaluation differs from a standard CT Calcium Score. A Calcium Score can only detect hardened or calcified plaque which is considered low risk and cannot assess for artery blockage. The coronary CTA with AI reports plaque burden, assesses coronary artery blood flow, and identifies all types of plaque build-up and the difference between high and low-risk plaque.

“This technology is revolutionary; it changes everything. It’s the heart’s version of “a picture is worth a thousand words,” says Kevin Young, MD.

While Longevity Health is focused on advanced cardiac imaging, additional prevention focused services are offered including echocardiogram, stress testing, EKG and full body contrast CT imaging to screen for various types of cancer. 

Dr. Kevin Young, Longevity Health’s Medical director is a board-certified cardiologist who can provide in-person consultations to review cardiac testing. Dr. Young is a nationally recognized, dual board-certified cardiologist with over twenty years of experience in clinical and invasive cardiology. A leader in his field, he has trained at top institutions including University of California, Los Angeles (UCLA) and University of Southern California (USC) and has served as a Clinical Associate Professor of Cardiology at UCLA, USC, and Vanderbilt.

Longevity Health is led by CEO Russell McBryde, a seasoned healthcare executive with more than twenty years of experience spearheading growth, driving innovation, and leading transformative efforts in the field of preventative care.

Every detail of the office has been thoughtfully designed with patient comfort and wellness in mind. From locally inspired artwork by DeAnn Hebert to a calming prep room complete with a recliner, the space reflects a warm, welcoming environment that helps patients feel at ease as they prepare for their coronary CTA. The integrated team at Longevity Health and Young Heart Group delivers a seamless, patient-centered experience marked by compassion, professionalism, and exceptional care. Servant-focused care is more than a value—it’s a daily practice. As an example, knowing patients must avoid caffeine prior to their coronary CTA, the team thoughtfully asks how each patient takes their coffee or tea so it’s brewed and waiting for them as soon as their scan is complete. It’s a small gesture with a big impact—bringing comfort and a personal touch to every visit.

Since opening in May 2025, Longevity Health has already helped save lives through advanced coronary CTA with AI-powered imaging. Several patients—completely asymptomatic—underwent preventive screening and were found to have high-risk plaque profiles requiring urgent cardiac intervention. While such critical findings aren’t the norm, this innovative approach enables earlier detection of heart disease, empowering patients to take control, slow disease progression, and significantly reduce their risk of future cardiac events.